(Q39411787)

11 September 2017

title

Variation of the glycosylation pattern in MUC1 glycopeptide BSA vaccines and its influence on the immune response (English)

1 reference

11 September 2017

1 reference

Hui Cai

1

1 reference

11 September 2017

Zhi-Hua Huang

2

1 reference

11 September 2017

Lei Shi

3

1 reference

11 September 2017

Zhan-Yi Sun

4

1 reference

11 September 2017

Yu-Fen Zhao

5

1 reference

11 September 2017

Horst Kunz

6

1 reference

11 September 2017

Yan-Mei Li

7

1 reference

11 September 2017

language of work or name

English

0 references

publication date

13 January 2012

1 reference

Angewandte Chemie International Edition

11 September 2017

published in

0 references

volume

51

1 reference

11 September 2017

issue

7

1 reference

11 September 2017

page(s)

1719-1723

1 reference

MUC1 immunobiology: from discovery to clinical applications

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

Robust immune responses elicited by a fully synthetic three-component vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

Synthetic antitumor vaccines from tetanus toxoid conjugates of MUC1 glycopeptides with the Thomsen-Friedenreich antigen and a fluorine-substituted analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

Mucins in cancer: protection and control of the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

Sulphotransferases acting on mucin-type oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

O-linked glycosylation in the mammary gland: changes that occur during malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

Synthetic glycopeptides from the mucin family as potential tools in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

Role of E box and initiator region in the expression of the rat follicle-stimulating hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

Serine versus threonine glycosylation: the methyl group causes a drastic alteration on the carbohydrate orientation and on the surrounding water shell

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

MUC1 glycoforms in breast cancer--cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

Tumor-Associated MUC1 Tandem-Repeat Glycopeptide Microarrays to Evaluate Serum- and Monoclonal-Antibody Specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

The human tumour-associated epithelial mucins are coded by an expressed hypervariable gene locus PUM

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201106396

21 January 2018

Identifiers

DOI

10.1002/ANIE.201106396

1 reference

11 September 2017

1 reference